{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:15:38Z","timestamp":1773285338976,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.clinthera.2005.09.003","type":"journal-article","created":{"date-parts":[[2005,11,13]],"date-time":"2005-11-13T07:12:02Z","timestamp":1131865922000},"page":"1383-1391","source":"Crossref","is-referenced-by-count":31,"title":["Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: A 12-month, double-blind, randomized clinical trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arrigo F.G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio V.","family":"Gaddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardina","family":"Ciccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario N.","family":"Piccinni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibilla","family":"Salvadeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Pricolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Fogari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morena","family":"Ghelfi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Fogari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2005.09.003_bib1","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2005.09.003_bib2","first-page":"S1","article-title":"Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Clinical practice recommendations 2002","volume":"25","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.09.003_bib3","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0149-2918(02)80076-5","article-title":"Pharmacologic management of diabetic nephropathy","volume":"24","author":"Vivian","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2005.09.003_bib4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2005.09.003_bib5","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/S0149-2918(03)80201-1","article-title":"A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2005.09.003_bib6","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1046\/j.1464-5491.2001.00582.x","article-title":"Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients","volume":"18","author":"Charpentier","year":"2001","journal-title":"Diabet Med."},{"issue":"Suppl 6a","key":"10.1016\/j.clinthera.2005.09.003_bib7","doi-asserted-by":"crossref","first-page":"15S","DOI":"10.1016\/S0002-9343(00)00338-7","article-title":"Combining sulfonylureas and other oral agents","volume":"108","author":"Riddle","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2005.09.003_bib8","series-title":"Recommendations Guiding Medical Doctors in Biomedical Research Involving Human Subjects","year":"1989"},{"key":"10.1016\/j.clinthera.2005.09.003_bib9","first-page":"S21","article-title":"Screening for diabetes (Position Statement)","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.09.003_bib10","article-title":"Obesity: Preventing and Managing the Global Epidemic","year":"1997"},{"key":"10.1016\/j.clinthera.2005.09.003_bib11","first-page":"151","article-title":"Guidelines Subcommittee. 1999 WHO-ISH Guidelines for the Management of Hypertension","volume":"17","author":"World Health Organization-International Society of Hypertension (WHO-ISH)","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2005.09.003_bib12","first-page":"S44","article-title":"Nutrition recommendations and principles for people with diabetes mellitus (Position Statement)","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.09.003_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1126\/science.635569","article-title":"The glycosylation of haemoglobin: Relevance to diabetes mellitus","volume":"200","author":"Bunn","year":"1978","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2005.09.003_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1464-5491.1999.00166.x","article-title":"A desktop guide to type 2 diabetes mellitus","volume":"16","year":"1999","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2005.09.003_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF01225569","article-title":"Determination of total serum insulin (IRI) in insulin-treated diabetic patients","volume":"8","author":"Heding","year":"1972","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2005.09.003_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2005.09.003_bib17","series-title":"Statistical Principles in Experimental Design","author":"Winer","year":"1971"},{"key":"10.1016\/j.clinthera.2005.09.003_bib18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1056\/NEJM200004273421707","article-title":"Evaluation of abnormal liver-enzyme results in asymptomatic patients","volume":"342","author":"Pratt","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.09.003_bib19","doi-asserted-by":"crossref","first-page":"6S5","DOI":"10.1016\/S1262-3636(03)72782-7","article-title":"Is metformin more than an oral hypoglycaemic agent?","volume":"29","author":"Vague","year":"2003","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.clinthera.2005.09.003_bib20","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/diacare.25.12.2244","article-title":"Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes","volume":"25","author":"Johnson","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2005.09.003_bib21","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) [published correction appears in Lancet. 1998;352:1557]","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2005.09.003_bib22","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2005.09.003_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1517\/14656566.2.4.699","article-title":"Clinical review of glimepiride","volume":"2","author":"McCall","year":"2001","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2005.09.003_bib24","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00003495-199855040-00007","article-title":"Glimepiride. A review of its use in the management of type 2 diabetes mellitus","volume":"55","author":"Langtry","year":"1998","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2005.09.003_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/13543784.12.7.1179","article-title":"Thiazolidinediones\u2014some recent developments","volume":"12","author":"Stumvoll","year":"2003","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.clinthera.2005.09.003_bib26","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/diabetes.52.6.1364","article-title":"Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes","volume":"52","author":"Bajaj","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2005.09.003_bib27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1464-5491.2002.00663.x","article-title":"Vascular effects of glibenclamide vs. glimepiride and metformin in type 2 diabetic patients","volume":"19","author":"Abbink","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/j.clinthera.2005.09.003_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1463-1326.2003.00258.x","article-title":"Addition of rosiglitazone to metformin is most effective in obese, insulin-resistant patients with type 2 diabetes","volume":"5","author":"Jones","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.clinthera.2005.09.003_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0895-7061(03)00911-7","article-title":"Treatment with rosiglitazone reduces hyperinsulinemia and improves arterial elasticity in patients with type 2 diabetes mellitus [published correction appears in Am J Hypertens. 2003;16:894]","volume":"16","author":"Shargorodsky","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2005.09.003_bib30","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0149-2918(03)80090-5","article-title":"Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: A one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors","volume":"25","author":"Derosa","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2005.09.003_bib31","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0149-2918(04)90074-4","article-title":"Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial","volume":"26","author":"Derosa","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2005.09.003_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/diabetes.52.2.283","article-title":"Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects","volume":"52","author":"Virtanen","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2005.09.003_bib33","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.2165\/00003495-200363130-00004","article-title":"Thiazolidinediones in type 2 diabetes mellitus: Current clinical evidence","volume":"63","author":"Diamant","year":"2003","journal-title":"Drugs"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291805001682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,20]],"date-time":"2019-01-20T21:20:09Z","timestamp":1548019209000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291805001682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0149291805001682"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2005.09.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]}}}